Formula for Success
Increased adoption of new technologies like telemedicine, virtual clinical trials, and AI are reshaping the life sciences industry. Successful organizations derive value from mining data to deliver personalized solutions that meet consumer demands. Leverage solutions that cover all technical aspects of scientific, engineering, and clinical research projects and programs across the Pharma and Biotechnology, MedTech, eClinical, and Materials Science industries.
Engage External Data
Democratization of drug and health information through social networks is more prevalent and important than ever before.
Improve Drug Efficacy
Pay-for-Performance/Outcomes demands that pharma companies demonstrate drug/therapy value beyond clinical trials.
Enhance the Experience
Patients, payers, and doctors have vastly different customer personas and demand digital experiences catered to their needs.
Connect with Digital
Partnerships improve collaboration across extended ecosystems which present regulatory and cybersecurity challenges.
Accelerate the Lifecycle
AI and ML are disrupting the sector around medical imaging, patient management, treatment planning and drug creation.
As Vice President, Matt oversees all Life Sciences and Engineering accounts including verticals such as pharmaceutical and biotechnology, medical device, contract services, research organization and universities, materials sciences, consumer goods, and chemicals.